approval
saveDIPRIVAN (PROPOFOL) — FDA approval
community read0 votes
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- phase 2 completionChongqing Medical University Hospital 2 — propofol (Phase II Trial Completion)Apr 30, 2026 · 154d ago
- phase 2 completionXijing Hospital — propofol (Phase II Trial Completion)Apr 24, 2026 · 160d ago
- approvalPROPOFOL — FDA approvalSep 19, 2025 · 377d ago
- approvalDIPRIVAN (PROPOFOL) — FDA approvalAug 31, 2022 · 1492d ago
- approvalDIPRIVAN (PROPOFOL) — FDA approvalMay 11, 2021 · 1969d ago
- approvalDIPRIVAN (PROPOFOL) — FDA approvalApr 27, 2017 · 3444d ago
- approvalPROPOFOL — FDA approvalMay 29, 2016 · 3777d ago
- approvalDIPRIVAN (PROPOFOL) — FDA approvalApr 17, 2015 · 4185d ago
same company · ±60 days · 6
- device recallFresenius Kabi USA, LLC device recall (Cls II)Nov 21, 2025
- approvalDALBAVANCIN HYDROCHLORIDE — FDA approvalNov 26, 2025
- device recallFresenius Kabi USA, LLC device recall (Cls I)Nov 14, 2025
- approvalDALBAVANCIN HYDROCHLORIDE: DALBAVANCIN HYDROCHLORIDE — FDA approvalNov 10, 2025
- recallFresenius Kabi USA, LLC recall (Cls I)Dec 3, 2025
- device recallFresenius Kabi USA, LLC device recall (Cls II)Nov 3, 2025
comments(0)
5-min edit window · permanent after that